Lilly - About the company
Lilly is a public company based in Indianapolis (United States), founded in 1876 by Eli Lilly. It operates as a Developer of traditional pharmaceutical medicines. Lilly has raised an undisclosed amount in funding. The company has 1988 active competitors, including 102 funded and 207 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.
Company Details
Developer of traditional pharmaceutical medicines. It produces medicines in oncology, cardiovascular, diabetes, critical care, neuroscience, men’s health, and musculoskeletal fields. In 2022, the company recorded annual revenues of $28.54B and a net profit of $6.24B.
- Website
- lilly.com
- Email ID
- *****@lilly.com
- Phone Number
- +1 **********
- Registered Address
- PLOT NO-92SECTOR 32 GURGAON, HARYANA, Haryana, India, 122001
Key Metrics
Founded Year
1876
Location
Indianapolis, United States
Stage
Public
Latest Funding Round
Investors
Ranked
5th among 1988 active competitors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
57,581 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Lilly
Lilly is associated with 5 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LILLY HQ ApS CIN: 41281782 , Denmark, Active | Apr 02, 2020 | - | - | |
LILLY A/S CIN: 29606668 , Denmark, Active | May 29, 2006 | - | - | |
Eli Lilly & Co CIN: 59478 , United States, Active | $1B+ (As on Dec 31, 2025) | 39000 (As on Dec 31, 2022) | - | |
ELI LILLY SERVICES INDIA PRIVATE LIMITED CIN: U72200KA2015FTC082300 , India, Active | Aug 17, 2015 | ₹1,000+ Cr (As on Mar 31, 2025) | 2872 (As on Jan 31, 2024) | |
ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED CIN: U24239HR1993PTC034844 , India, Active | Mar 18, 1993 | ₹1,000+ Cr (As on Mar 31, 2025) | - |
Lilly's IPO details
Lilly got listed on Jan 06, 1978.
Click here to take a look at Lilly's IPO in detail
Sign up to download Lilly's company profile
Lilly's funding and investors
Lilly has raised funding over 9 rounds. Its first funding round was on Jun 28, 2007. Its latest funding round was a Post IPO round on 2020 for $*****. 1 investor participated in its latest round. Lilly has 13 institutional investors.
Here is the list of recent funding rounds of Lilly:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2020 | 3840 | Post IPO | 4883 | 4445 | 7826 | 8112 |
Mar 03, 2019 | 3716439 | Conventional Debt | 5703285 | 2382801 | 2303434 | 7789431 |
Aug 01, 2018 | 5836723 | Grant (prize money) | 8023698 | 5184592 | 7936707 |
View details of Lilly's funding rounds and investors
Lilly's founders and board of directors
Founder? Claim ProfileThe founders of Lilly is Eli Lilly.
Here are the details of Lilly's key team members:
- Eli Lilly: Founder of Lilly. They are also an angel investor in 15 startups.
View details of Lilly's Founder profiles and Board Members
Lilly's employee count trend
Lilly has 57,581 employees as of Aug 26. Here is Lilly's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Lilly's Competitors and alternates
Top competitors of Lilly include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Lilly, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
3rd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
4th | AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
6th | Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 75/100 | |
7th | Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 71/100 | |
8th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
9th | Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 68/100 |
Looking for more details on Lilly's competitors? Click here to see the top ones
Lilly's Investments and acquisitions
Lilly has made 147 investments in companies including General Medicine and BigHat. Lilly has also acquired 40 companies including Meridabio and AtaiBeckley.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 06, 2026 | Investments | 2023 | Salt Lake City (United States) | |
Sep 24, 2026 | Investments | 2019 | San Carlos (United States) | |
Sep 16, 2026 | Investments | 2014 | San Francisco (United States) |
See all investments and acquisitions by Lilly
Reports related to Lilly
Here is the latest report on Lilly's sector:
News related to Lilly
Media has covered Lilly for a total of 640 events in the last 1 year, 356 of them have been about company updates and 59 about partnerships.
•
•
Breast Cancer Awareness Month Raises Questions About Antipsychotic Drug WarningsPR Newswire•Oct 07, 2026•Lilly, Wisner Baum, Johnson & Johnson
•
General Medicine Secures $120 Million in Series B Funding to Expand Healthcare StorePR Newswire•Oct 06, 2026•General Medicine, Andreessen Horowitz, Mercy Health, Vxi Capital and 2 others
•
Eli Lilly (LLY) Has Massive Growth Opportunities Beyond Weight Loss DrugsWall St.•Oct 06, 2026•Lilly
•
•
RTX lands $24.4bn SM-6 deal days after $20.7bn AMRAAM contractBusiness News Today•Oct 03, 2026•RTX, Trilogy, Lilly, IBM
•
•
•
•
Eli Lilly's Foundayo Shows Promising Weight Loss and A1C Reduction in Comparative Analysisclinicaltrialsarena.com•Sep 30, 2026•Lilly
Are you a Founder ?
FAQs about Lilly
Explore our recently published companies
- Christoph Hein - Lemwerder based, Unfunded company
- Sandra Godwin - Unfunded company
- KCG - Unfunded company
- Omnipresence Exim - Hyderabad based, 2019 founded, Unfunded company
- ValaCare - Toronto based, 2026 founded, Unfunded company
- AI Fairness 360 - Unfunded company